Insider Transaction Report for Mira LaCous

Mira LaCous, Chief Technology Officer of BIO KEY INTERNATIONAL INC, acquired 250 shares of Common Stock on June 30, 2026, at a price of $3.83 per share. This acquisition was made under the BIO-key International, Inc. 2021 Employee Stock Purchase Plan, as amended, in a transaction exempt under Rule 16b-3(d) and Rule 16b-3(c). Following this transaction, Ms. LaCous owns 4076 shares of Common Stock. All share amounts have been adjusted to reflect BIO-key's 1-for-10 reverse stock split, effective April 30, 2026. The filing is an insider transaction report (Form 4).